본문 바로가기
KERD
논문KCI 등재

Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center

2

조회

0

다운로드

14

인용

0

참고문헌

키워드

주제분류내과학

초록

Background/Aims: Endoscopic submucosal dissection (ESD) of a superficial esophageal neoplasm (SEN) is a technically difficult procedure. We investigated the clinical outcomes of ESD to determine its feasibility and effectiveness for the treatment of SEN. Methods: Patients who underwent ESD for SEN between August 2005 and June 2014 were eligible for this study. The clinical features of patients and tumors, histopathologic characteristics, adverse events, results of endoscopic resection, and survival were investigated. Results: ESD was performed in 225 patients with 261 lesions, including 70 cases (26.8%) of dysplasias and 191 cases (73.2%) of squamous cell carcinomas. The median age was 65 years (range, 44 to 86), and the male to female ratio was 21.5:1. Median tumor size was 37 mm (range, 5 to 85) and median procedure time was 45 minutes (range, 9 to 160). En bloc resection was performed in 245 of 261 lesions (93.9%), with complete resection in 234 lesions (89.7%) and curative resection in 201 lesions (77.0%). Adverse events occurred in 33 cases (12.6%), including bleeding (1.5%), perforation (4.6%), and stricture (6.5%). During a median follow-up period of 35.0 months (interquartile range, 18 to 62), none of the patients showed local recurrence. The 5-year overall and disease-specific survival rates were 89.7% and 100%, respectively. Conclusions: ESD is a feasible and effective procedure for the treatment of SEN based on our 10-year experience, which showed favorable outcomes.

Abstract

Background/Aims: Endoscopic submucosal dissection (ESD) of a superficial esophageal neoplasm (SEN) is a technically difficult procedure. We investigated the clinical outcomes of ESD to determine its feasibility and effectiveness for the treatment of SEN. Methods: Patients who underwent ESD for SEN between August 2005 and June 2014 were eligible for this study. The clinical features of patients and tumors, histopathologic characteristics, adverse events, results of endoscopic resection, and survival were investigated. Results: ESD was performed in 225 patients with 261 lesions, including 70 cases (26.8%) of dysplasias and 191 cases (73.2%) of squamous cell carcinomas. The median age was 65 years (range, 44 to 86), and the male to female ratio was 21.5:1. Median tumor size was 37 mm (range, 5 to 85) and median procedure time was 45 minutes (range, 9 to 160). En bloc resection was performed in 245 of 261 lesions (93.9%), with complete resection in 234 lesions (89.7%) and curative resection in 201 lesions (77.0%). Adverse events occurred in 33 cases (12.6%), including bleeding (1.5%), perforation (4.6%), and stricture (6.5%). During a median follow-up period of 35.0 months (interquartile range, 18 to 62), none of the patients showed local recurrence. The 5-year overall and disease-specific survival rates were 89.7% and 100%, respectively. Conclusions: ESD is a feasible and effective procedure for the treatment of SEN based on our 10-year experience, which showed favorable outcomes.

참고문헌 (43)

  1. Siegel R, "Cancer statistics, 2014", CA Cancer J Clin, 64, pp.9~29 (2014)
  2. Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
  3. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회[DOI]
  4. Kumagai Y, "Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system", Endoscopy, 36, pp.590~594 (2004)
  5. Yoshida T, "Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions", Gastrointest Endosc, 59, pp.288~295 (2004)
  6. Kodashima S, "Ex-vivo study of high-magnification chromoendoscopy in the gastrointestinal tract to determine the optimal staining conditions for endocytoscopy", Endoscopy, 38, pp.1115~1121 (2006)
  7. Kato H, "Superficial esophageal carcinoma: surgical treatment and the results", Cancer, 66, pp.2319~2323 (1990)
  8. Kato H, "Cervical, mediastinal, and abdominal lymph node dissection(three-field dissection) for superficial carcinoma of the thoracic esophagus", Cancer, 72, pp.2879~2882 (1993)
  9. Roth JA, "Surgery for cancer of the esophagus", Semin Oncol, 21, pp.453~461 (1994)
  10. Pech O, "Endoscopic resection of superficial esophageal squamous-cell carcinomas: Western experience", Am J Gastroenterol, 99, pp.1226~1232 (2004)
  11. Higuchi K, "Expansion of the indications for endoscopic mucosal resection in patients with superficial esophageal carcinoma", Endoscopy, 39, pp.36~40 (2007)
  12. Ciocirlan M, "Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus", Endoscopy, 39, pp.24~29 (2007)
  13. Pech O, "Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia", Endoscopy, 39, pp.30~35 (2007)
  14. Ono H, "Endoscopic mucosal resection for treatment of early gastric cancer", Gut, 48, pp.225~229 (2001)
  15. Oyama T, "Endoscopic submucosal dissection of early esophageal cancer", Clin Gastroenterol Hepatol, 3(7 Suppl 1), pp.S67~S70 (2005)
  16. Ishihara R, "Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan", Gastrointest Endosc, 68, pp.1066~1072 (2008)
  17. Katada C, "Local recurrence of squamous-cell carcinoma of the esophagus after EMR", Gastrointest Endosc, 61, pp.219~225 (2005)
  18. Esaki M, "Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection", Endoscopy, 39, pp.41~45 (2007)
  19. Ishihara R, "Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection", Gastrointest Endosc, 67, pp.799~804 (2008)
  20. Hammad H, "Endoscopic submucosal dissection for malignant esophageal lesions", Curr Gastroenterol Rep, 16, pp.386~ (2014)
  21. Ishihara R, "Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection", Cancer, 112, pp.2166~2172 (2008)
  22. Takahashi H, "Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video)", Gastrointest Endosc, 72, pp.255~264 (2010)
  23. Yamashina T, "Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma", Am J Gastroenterol, 108, pp.544~551 (2013)
  24. Repici A, "Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series", Gastrointest Endosc, 71, pp.715~721 (2010)
  25. Ono S, "Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms", Gastrointest Endosc, 70, pp.860~866 (2009)
  26. 김도훈, "Endoscopic and Oncologic Outcomes of Endoscopic Resection for Superficial Esophageal Neoplasm", Gut and Liver, 9(4), pp.470~477 (2015), 거트앤리버 발행위원회
  27. Kodama M, "Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan", Surgery, 123, pp.432~439 (1998)
  28. Japan Esophageal Society, "Japanese Classification of Esophageal Cancer, tenth edition: part I", Esophagus, 6, pp.1~25 (2009)
  29. Chiba T, "Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma: implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection", Dis Esophagus, 23, pp.398~407 (2010)
  30. Ono S, "Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms", Endoscopy, 41, pp.661~665 (2009)
  31. Fujita H, "Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy", World J Surg, 25, pp.424~431 (2001)
  32. Katada C, "Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae:a multicenter retrospective cohort study", Endoscopy, 39, pp.779~783 (2007)
  33. Shimizu Y, "Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper", Gastrointest Endosc, 56, pp.387~390 (2002)
  34. Fujishiro M, "Endoscopic submucosal dissection of esophageal squamous cell neoplasms", Clin Gastroenterol Hepatol, 4, pp.688~694 (2006)
  35. Mizuta H, "Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer", Dis Esophagus, 22, pp.626~631 (2009)
  36. Messmann H, "Management of endoscopic submucosal dissection complications", Endoscopy, 41, pp.712~714 (2009)
  37. Shi Q, "Risk factors for postoperative stricture after endoscopic submucosal dissection for superficial esophageal carcinoma", Endoscopy, 46, pp.640~644 (2014)
  38. Sato H, "Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone", Gastrointest Endosc, 78, pp.250~257 (2013)
  39. Yamaguchi N, "Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma", Gastrointest Endosc, 73, pp.1115~1121 (2011)
  40. Yamaguchi N, "Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report", Digestion, 83, pp.291~295 (2011)
  41. Isomoto H, "Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma", BMC Gastroenterol, 11, pp.46~ (2011)
  42. Hashimoto S, "The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection", Gastrointest Endosc, 74, pp.1389~1393 (2011)
  43. 이욱진, "Intralesional Steroid Injection to Prevent Stricture after Near-Circumferential Endosopic Submucosal Dissection for Superficial Esophageal Cancer", Clinical Endoscopy, 46(6), pp.643~646 (2013), 대한소화기내시경학회

관련 논문AI추천

Clinical Outcomes of Endoscopic Submucosal Dissection for Superficial Esophageal Squamous NeoplasmsHyojin Park, Jae Jun Park, Jie-Hyun Kim, Jung Soo Park, Young Hoon Youn대한소화기내시경학회 · Clinical Endoscopy2016 · 제49권 제2호Endoscopic and Oncologic Outcomes of Endoscopic Resection for Superficial Esophageal Neoplasm공은정, 김도훈, 김미영, 김진호, 박영수, 백승희, 송호준, 안지영, 이긴형, 이정훈, 정훈영, 최기돈, 최기숙, 최지영거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제4호Long-Term Outcome after Endoscopic Submucosal Dissection in Patients with Superficial Esophageal Squamous Cell Carcinoma: A Single-Center Study김광하, 박도윤, 송근암, 주동찬, 지준형거트앤리버 소화기연관학회협의회 · Gut and Liver2014 · 제8권 제6호Outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms in patients with liver cirrhosisDo Hoon Kim, Gin Hyug Lee, Hee Kyong Na, Ho June Song, Hwoon-Yong Jung, Jeong Hoon Lee, Jin Hee Noh, Ji Yong Ahn, Kee Don Choi, Kee Wook Jung, Young Kwon Choi대한소화기내시경학회 · Clinical Endoscopy2022 · 제55권 제3호Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: long-term follow-up in a Western centerAlanna Ebigbo, Andreas Probst, Bernd Geissler, Bruno Märkl, Carola Fleischmann, Gernot Müller, Helmut Messmann, Stefan Eser, Stefan Schiele, Tina Schaller대한소화기내시경학회 · Clinical Endoscopy2023 · 제56권 제1호Management of esophageal neoplasms by endoscopic submucosal dissection: experience over 100 consecutive proceduresDanilo Carvalho, Josué Aliaga Ramos, Moises Salgado Pedrosa, Takashi Toyonaga, Vitor N. Arantes, Yoshinori Morita대한소화기내시경학회 · Clinical Endoscopy2023 · 제56권 제5호

이 간행물의 다른 논문 (24건)